PUBLIC COMPANY BRIEF
Reverie Labs
Engineering next-generation, brain-penetrant cancer therapies.
- YC batch
- Winter 2018
- Reported status
- inactive
- Reported location
- Boston, MA, USA; Cambridge, MA, USA
This company is under editorial review. No thesis, playbook, or prompt is for sale.